HER-2 codon 655 polymorphism in cervical carcinogenesis

Int J Gynecol Cancer. 2006 Jan-Feb;16(1):325-8. doi: 10.1111/j.1525-1438.2006.00349.x.

Abstract

HER-2 codon 655 polymorphism together with human papillomavirus (HPV) types were examined in a total of 279 cervical smear samples. Forty-nine patients with high-grade squamous intraepithelial lesion had higher frequency of high-risk HPV than 167 patients with low-grade squamous intraepithelial lesion and 63 controls. There was no statistical difference in the frequencies of HER-2 Ile/Ile, Ile/Val, and Val/Val genotypes between squamous intraepithelial lesions (SILs) and controls. When the Ile/Ile genotype was compared to the Ile/Val + Val/Val genotypes, there was also no statistical difference in the genotype prevalence between SILs and controls either in 91 or 188 patients with or without high-risk HPV, respectively. These results suggest that the HER-2 polymorphism at codon 655 in cervical cell samples is unlikely to be associated with HPV status and the onset of cervical cancer in a Japanese population.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Carcinoma, Squamous Cell / epidemiology
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / pathology
  • Case-Control Studies
  • Chi-Square Distribution
  • Codon
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genes, erbB-2
  • Genotype
  • Humans
  • Incidence
  • Japan / epidemiology
  • Mass Screening
  • Molecular Sequence Data
  • Neoplasm Staging
  • Papillomaviridae / isolation & purification
  • Papillomavirus Infections / diagnosis*
  • Papillomavirus Infections / epidemiology
  • Polymorphism, Genetic*
  • Risk Assessment
  • Sampling Studies
  • Sensitivity and Specificity
  • Statistics, Nonparametric
  • Uterine Cervical Neoplasms / epidemiology
  • Uterine Cervical Neoplasms / genetics*
  • Uterine Cervical Neoplasms / pathology*
  • Vaginal Smears

Substances

  • Codon